MontiFast 5 mg (Tablet)

Unit Price: ৳ 7.50 (2 x 10: ৳ 150.00)

Strip Price: ৳ 75.00

Medicine Details

Category	Details
Generic	Montelukast sodium
Company	Globe pharmaceuticals ltd
Also available as	Montifast 4 mg chewable tablet Montifast 10 mg tablet

Selective and orally active leukotriene receptor antagonist
Prophylaxis and chronic treatment of asthma
Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis

Dosage for adults and adolescents 15 years of age and older: Montelukast 10 mg tablet once daily
Dosage for pediatric patients 6 to 14 years of age: Montelukast 5 mg tablet once daily
Dosage for pediatric patients 2 years to 5 years of age: Montelukast 4 mg tablet once daily
Dosage for pediatric patients 6 months to 5 years of age: Montelukast 4 mg oral granules once daily
Hepatic Insufficiency: No dosage adjustment is required
Renal Insufficiency: No dosage adjustment is recommended
Elderly use: No dosage adjustment is required

No increase in adverse reactions when administered with other therapies for asthma
Clinical dose did not have clinically important effects on the pharmacokinetics of specific drugs
No evidence of clinical adverse interactions with a wide range of commonly prescribed drugs
Phenobarbital decreased the AUC of MontiFast by approximately 40%

Common: Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection
Uncommon: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders
Rare: Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor

Not indicated for use in the reversal of bronchospasm in acute asthma attacks
Appropriate rescue medication should be available
MontiFast can be continued during acute exacerbations of asthma
Should not be abruptly substituted for inhaled or oral corticosteroids
Not to be used as monotherapy for the treatment and management of exercise induced bronchospasm
Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents

MolecularFormula: C35H36ClNO3S
ChemicalStructureImage: https://medex.com.bd/storage/res/g-res-768-montelukast-sodium-chemical-structure-drK1lRHjspWQ7613gJoZ.svg